Granules India Ltd — Profit & Loss Statement

₹620.40

-0.75%

Granules India Ltd Profit & Loss Statement (Annual)

Metric	2025	2024	2023	2022	2021
Tax Effect Of Unusual Items	7.39 Cr	0.00	-0.35 Cr	-1.25 Cr	—
Tax Rate For Calcs	0.24	0.26	0.25	0.26	—
Normalized EBITDA	958.15 Cr	860.38 Cr	908.51 Cr	733.26 Cr	—
Total Unusual Items	30.75 Cr	0.00	-1.43 Cr	-4.78 Cr	—
Total Unusual Items Excluding Goodwill	30.75 Cr	0.00	-1.43 Cr	-4.78 Cr	—
Net Income From Continuing Operation Net Minority Interest	501.52 Cr	405.31 Cr	516.60 Cr	412.76 Cr	—
Reconciled Depreciation	225.50 Cr	207.33 Cr	184.49 Cr	158.63 Cr	—
Reconciled Cost Of Revenue	1.73K Cr	2.02K Cr	2.38K Cr	1.96K Cr	—
EBITDA	988.90 Cr	860.38 Cr	907.09 Cr	728.47 Cr	—
EBIT	763.40 Cr	653.05 Cr	722.60 Cr	569.84 Cr	—
Net Interest Income	-103.24 Cr	-105.82 Cr	-51.42 Cr	-10.36 Cr	—
Interest Expense	103.24 Cr	105.82 Cr	35.42 Cr	11.84 Cr	—
Normalized Income	478.16 Cr	405.31 Cr	517.67 Cr	416.30 Cr	—
Net Income From Continuing And Discontinued Operation	501.52 Cr	405.31 Cr	516.60 Cr	412.76 Cr	—
Total Expenses	3.74K Cr	3.84K Cr	3.76K Cr	3.15K Cr	—
Diluted NI Availto Com Stockholders	501.52 Cr	405.31 Cr	516.60 Cr	412.76 Cr	—
Net Income Common Stockholders	501.52 Cr	405.31 Cr	516.60 Cr	412.76 Cr	—
Otherunder Preferred Stock Dividend	0.00	0.00	0.00	0.00	—
Net Income	501.52 Cr	405.31 Cr	516.60 Cr	412.76 Cr	—
Net Income Including Noncontrolling Interests	501.52 Cr	405.31 Cr	516.60 Cr	412.76 Cr	—
Net Income Continuous Operations	501.52 Cr	405.31 Cr	516.60 Cr	412.76 Cr	—
Tax Provision	158.66 Cr	141.92 Cr	170.58 Cr	145.24 Cr	—
Pretax Income	660.17 Cr	547.23 Cr	687.17 Cr	558.00 Cr	—
Other Non Operating Income Expenses	12.92 Cr	4.40 Cr	9.27 Cr	4.75 Cr	—
Special Income Charges	30.75 Cr	0.00	-1.43 Cr	-4.78 Cr	—
Net Non Operating Interest Income Expense	-103.24 Cr	-105.82 Cr	-51.42 Cr	-10.36 Cr	—
Interest Expense Non Operating	103.24 Cr	105.82 Cr	35.42 Cr	11.84 Cr	—
Operating Income	719.74 Cr	648.65 Cr	737.70 Cr	574.90 Cr	—
Operating Expense	2.01K Cr	1.82K Cr	1.38K Cr	1.19K Cr	—
Other Operating Expenses	1.15K Cr	1.03K Cr	250.16 Cr	219.56 Cr	—
Depreciation And Amortization In Income Statement	225.50 Cr	207.33 Cr	184.49 Cr	158.63 Cr	—
Depreciation Income Statement	225.50 Cr	207.33 Cr	142.95 Cr	122.25 Cr	—
Gross Profit	2.73K Cr	2.47K Cr	2.11K Cr	1.77K Cr	—
Cost Of Revenue	1.73K Cr	2.02K Cr	2.38K Cr	1.96K Cr	—
Total Revenue	4.46K Cr	4.49K Cr	4.50K Cr	3.73K Cr	—
Operating Revenue	4.46K Cr	4.49K Cr	4.50K Cr	3.73K Cr	—
Interest Income	—	2.80 Cr	4.51 Cr	12.85 Cr	12.38 Cr
Rent Expense Supplemental	—	21.98 Cr	11.16 Cr	7.97 Cr	7.83 Cr
Diluted Average Shares	—	24.24 Cr	24.57 Cr	24.86 Cr	25.03 Cr
Basic Average Shares	—	24.23 Cr	24.54 Cr	24.78 Cr	24.92 Cr
Diluted EPS	—	16.72	21.00	16.60	21.95
Basic EPS	—	16.73	21.05	16.66	22.05
Other Special Charges	—	2.32 Cr	1.37 Cr	4.78 Cr	0.39 Cr
Write Off	—	2.44 Cr	0.05 Cr	10000.00	2.46 Cr
Total Other Finance Cost	—	34.06 Cr	20.51 Cr	11.37 Cr	6.67 Cr
Interest Income Non Operating	—	2.80 Cr	4.51 Cr	12.85 Cr	12.38 Cr
Amortization	—	47.00 Cr	41.54 Cr	36.38 Cr	35.92 Cr
Research And Development	—	198.56 Cr	116.38 Cr	142.96 Cr	100.16 Cr
Selling General And Administration	—	375.76 Cr	353.87 Cr	298.89 Cr	197.36 Cr
Selling And Marketing Expense	—	290.63 Cr	280.00 Cr	247.45 Cr	159.80 Cr
General And Administrative Expense	—	85.13 Cr	73.88 Cr	51.44 Cr	37.56 Cr
Rent And Landing Fees	—	21.98 Cr	11.16 Cr	7.97 Cr	7.83 Cr
Minority Interests	—	—	0.00	0.00	0.00
Impairment Of Capital Assets	—	—	—	0.00	0.73 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Granules India Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.